Medco expands research efforts with $730M deal for trial technology developer United BioSource
Medco Health will buy United BioSource for $730M
NEW YORK — Pharmacy benefits manager Medco Health Solutions Inc. said Monday it will buy United BioSource Corp., which develops technology used in clinical trials and patient monitoring, for $730 million in cash.
United BioSource, based in Bethesda, Md., designs phone and web technologies that clinical trial patients can …. Original article on Gaea Times at : Medco expands research efforts with $730M deal for trial technology developer United BioSource.